Adopting the new iStopMM-based criteria for light-chain monoclonal gammopathy of undetermined significance: an ongoing debate

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2024-09-12
DOI
https://doi.org/10.3324/haematol.2024.286239
Citations
3
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.70
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adopting the new iStopMM-based criteria for light-chain monoclonal gammopathy of undetermined significance: an ongoing debate

Anat Reiner‐Benaim, Guy Melamed, Tamir Shragai, Yael Chava Cohen et al.
3 citations
Haematologica
Amyloidosis: Diagnosis, Treatment, Outcomes
0.70
article

Adopting the new iStopMM-based criteria for light-chain monoclonal gammopathy of undetermined significance: an ongoing debate

Anat Reiner‐Benaim, Guy Melamed, Tamir Shragai, Yael Chava Cohen, Irit Avivi, Dor Shpitzer
article en
3 citations

Abstract

No abstract available for this paper.
HaematologicaVol. 110(2)
Ben-Gurion University of the Negev (IL), Tel Aviv Sourasky Medical Center (IL), Maccabi Healthcare Services (IL), Maccabi Institute for Health Services Research (IL)
Openalex Percentile: Top 30%
Amyloidosis: Diagnosis, Treatment, Outcomes
0.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Adopting the new iStopMM-based criteria for light-chain monoclonal gammopathy of undetermined significance: an ongoing debate — Anat Reiner‐Benaim, Guy Melamed, et al. · Haematologica (2024) | TGRS Research Map | TGRS